Polpharma Pharmaceutical Works - API Manufacturer

Successful GMP audit by Japanese companies

Polpharma Fine Chemicals Business Unit passed successfully inspection by two of the major generic Japanese pharma companies. The audits took place between 24 and 30 of June 2010 and covered the manufacturing and control systems for Alendronate sodium and Risedronate sodium.

Since the beginning of 2010 Polpharma Fine Chemicals counts nine positive customer audits and another seven are expected in the near future. This proves the confidence customers are placing with us in the manufacture of APIs of the highest product quality.